A New Long Acting Formulation of the Luteinizing Hormone-Releasing Hormone Analogue, Goserelin: Results of Studies in Prostate Cancer
- 1 April 1996
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of Urology
- Vol. 155 (4), 1352-1354
- https://doi.org/10.1016/s0022-5347(01)66264-5
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Comparison of LHRH Analogue (Zoladex) with Orchiectomy in Patients with Metastatic Prostatic CarcinomaBritish Journal of Urology, 1991
- Medical or surgical orchidectomy: the patients' choice.BMJ, 1991
- Orchidectomy or LHRH-Analogue? Which Do the Patients Prefer and What Treatment Would Norwegian Urologists Prefer if They Had Advanced Cancer of the Prostate?Scandinavian Journal of Urology and Nephrology, 1991
- Patients' choice of treatment in stage D prostate cancerUrology, 1989
- Long-Term Therapy with a Depot Luteinizing Hormone-Releasing Hormone Analogue (Zoladex) in Patients with Advanced Prostatic CarcinomaJournal of Urology, 1988
- How Would You Like to Have an Orchidectomy for Advanced Prostatic Cancer?American Journal of Clinical Oncology, 1988